Could non-hallucinogenic compounds derived from psychedelics be the next frontier in anti-inflammatory medicine? Researchers are exploring a new class of drugs, called PIPIs (Psychedelic drug Informed but Psychedelic-experience Inactive), which are derived from psychedelics but do not cause hallucinations. These compounds show promise in treating...
Can psychedelics help treat addiction by rebalancing brain chemistry? A review of recent studies suggests that psychedelics, particularly psilocybin, may help treat substance use disorders by balancing dopamine levels in the brain, which can reduce cravings and the risk of relapse. This article will delve...
Can ayahuasca-assisted therapy help people cope with prolonged grief after losing a loved one? A recent study has shown that ayahuasca-assisted meaning reconstruction therapy can significantly help individuals struggling with prolonged grief disorder. This article will examine the study's findings, how ayahuasca facilitates the grieving...
Can psilocybin-assisted therapy provide long-term remission from major depression? A long-term study has shown that 67% of participants with major depression were still in remission five years after psilocybin-assisted therapy. This article will explore the details of this study, the implications for long-term depression treatment,...